Now available in 31 countries for the treatment of autoimmune diseases Celltrion Healthcare has today announced the launch of Remsima™ (infliximab) in 12 European markets: Austria, Belgium, Denmark, France, Germany, Greece, Italy, Luxembourg, the Netherlands, Spain, S…
Source: Remsima (infliximab) now available in Europe for treatment of autoimmune diseases
Thursday, February 26, 2015
Remsima (infliximab) now available in Europe for treatment of autoimmune diseases
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment